Ascendiant Capital Maintains Buy on Myomo, Raises Price Target to $10.5
Ascendiant Capital analyst Edward Woo maintains Myomo (AMEX:MYO) with a Buy and raises the price target from $10 to $10.5.
Read original at benzingaStocks · News reference
Myomo Q2 EPS $(0.09) Beats $(0.10) Estimate, Sales $11.704M Beat $10.352M Estimate
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 5, 2026, 8:10 PM
- Checked
- Aug 5, 2026, 8:10 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Myomo Sees Q3 Sales $11.500M-$12.000M vs $11.168M Est
Myomo (AMEX:MYO) sees Q3 sales of $11.500 million-$12.000 million vs $11.168 million analyst estimate.
Read original at benzingaMyomo Raises FY2026 Sales Guidance from $43.000M-$46.000M to $45.000M-$47.000M vs $44.434M Est
Myomo (AMEX:MYO) raises FY2026 sales outlook from $43.000 million-$46.000 million to $45.000 million-$47.000 million vs $44.434 million estimate.
Read original at benzinga8-K filing — MYOMO, INC. (MYO)
Filed: 2026-08-05 AccNo: 0001193125-26-335109 Size: 752 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgar